Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance

THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE.

Journal of chronic diseases·2015

Rigorous new approach to constructing a gold standard for validating new diagnostic criteria, as exemplified by the eosinophilia-myalgia syndrome.

Archives of internal medicine·2001

The Blame-X syndrome: problems and lessons in nosology, spectrum, and etiology.

Journal of clinical epidemiology·2001

Presenting manifestations, cigarette smoking, and detection bias in age at diagnosis of lung cancer.

Annals of epidemiology·2001

A rating system for prompt clinical diagnosis of ischemic stroke.

Archives of medical research·2001

Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy.

Kidney international·2000

Exposure-Response Analysis of Enfortumab Vedotin Plus Pembrolizumab as First-Line Therapy for Locally Advanced or Metastatic Urothelial Cancer.

Clinical pharmacology and therapeutics·2026

How to Optimize Healthy Volunteer Screening and Enrolment in Clinical Trials: A Qualitative and Quantitative Approach to Evaluate Processes and Healthy Volunteers' Perceptions.

Clinical pharmacology and therapeutics·2026

Phase I Evaluation of Siltartoxatug, a First-in-Class Anti-Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations.

Clinical pharmacology and therapeutics·2026

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.

Clinical pharmacology and therapeutics·2026

Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.

Clinical pharmacology and therapeutics·2026

The Governance Gap: Democratizing Drug Development Through Decision Architecture.

Clinical pharmacology and therapeutics·2026

Brixadi for Stimulant Use Disorder: Evolving Pharmacologic Considerations and Clinical Implications.

Advances in therapy·2026

Current clinical applications and future developments of platinum-based anticancer drugs.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry·2026

Evaluating clinical characteristics and outcomes associated with body stuffers presenting to the emergency department: a five-year retrospective analysis from a United States poison center.

Clinical toxicology (Philadelphia, Pa.)·2026

Chronic Paraquat Neurotoxicity and Dopaminergic Degeneration: A Mechanistic Review.

Chemistry & biodiversity·2026

Real-Life Application of the Penicillin Allergy Decision Rule (PEN-FAST) Score in De-Labeling Penicillin Allergy: A Case Series.

Cureus·2026

Outcomes From the Use of Cefazolin for Surgical Prophylaxis in Patients Allergic to Penicillin.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026

Related Experiment Videos

Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance

Related Concept Videos

THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE.

Rigorous new approach to constructing a gold standard for validating new diagnostic criteria, as exemplified by the eosinophilia-myalgia syndrome.

The Blame-X syndrome: problems and lessons in nosology, spectrum, and etiology.

Presenting manifestations, cigarette smoking, and detection bias in age at diagnosis of lung cancer.

A rating system for prompt clinical diagnosis of ischemic stroke.

Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy.

Exposure-Response Analysis of Enfortumab Vedotin Plus Pembrolizumab as First-Line Therapy for Locally Advanced or Metastatic Urothelial Cancer.

How to Optimize Healthy Volunteer Screening and Enrolment in Clinical Trials: A Qualitative and Quantitative Approach to Evaluate Processes and Healthy Volunteers' Perceptions.

Phase I Evaluation of Siltartoxatug, a First-in-Class Anti-Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations.

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.

Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.

The Governance Gap: Democratizing Drug Development Through Decision Architecture.

Brixadi for Stimulant Use Disorder: Evolving Pharmacologic Considerations and Clinical Implications.

Current clinical applications and future developments of platinum-based anticancer drugs.

Evaluating clinical characteristics and outcomes associated with body stuffers presenting to the emergency department: a five-year retrospective analysis from a United States poison center.

Chronic Paraquat Neurotoxicity and Dopaminergic Degeneration: A Mechanistic Review.

Real-Life Application of the Penicillin Allergy Decision Rule (PEN-FAST) Score in De-Labeling Penicillin Allergy: A Case Series.

Outcomes From the Use of Cefazolin for Surgical Prophylaxis in Patients Allergic to Penicillin.

Related Experiment Videos

Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance

Related Concept Videos

Related Articles